Defining Optimal Health Range for Thyroid Function Based on the Risk of Cardiovascular Disease
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Context: Reference ranges of thyroid-stimulating hormone (TSH) and free thyroxine (FT4) are defined by their distribution in apparently healthy populations (2.5th and 97.5th percentiles), irrespective of disease risk, and are used as cutoffs for defining and clinically managing thyroid dysfunction. Objective: To provide proof of concept in defining optimal health ranges of thyroid function based on cardiovascular disease (CVD) mortality risk. Design and Participants: In all, 9233 participants from the Rotterdam Study (mean age, 65.0 years) were followed up (median, 8.8 years) from baseline to date of death or end of follow-up period (2012), whichever came first (689 cases of CVD mortality). Main Outcomes: We calculated 10-year absolute risks of CVD mortality (defined according to the SCORE project) using a Fine and Gray competing risk model per percentiles of TSH and FT4, modeled nonlinearly and with sex and age adjustments. Results: Overall, FT4 level >90th percentile was associated with a predicted 10-year CVD mortality risk >7.5% (P = 0.005). In men, FT4 level >97th percentile was associated with a risk of 10.8% (P < 0.001). In participants aged ≥65 years, absolute risk estimates were <10.0% below the 30th percentile (∼14.5 pmol/L or 1.10 ng/dL) and ≥15.0% above the 97th percentile of FT4 (∼22 pmol/L or 1.70 ng/dL). Conclusions: We describe absolute 10-year CVD mortality risks according to thyroid function (TSH and FT4) and suggest that optimal health ranges for thyroid function can be defined according to disease risk and are possibly sex and age dependent. These results need to be replicated with sufficient samples and representative populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“There is increasing evidence that variation in thyroid status within the reference range is a risk factor for disease burden.[115][116][117][118]”
From Hypothyroidism (2024) · cites this paper as [117]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
The burden of disease in older people and implications for health policy and practice
Prince, M. J., Wu, F., Guo, Y., Gutierrez Robledo, L. M., O'Donnell, M., Sullivan, R., & Yusuf, S. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61347-7 · Cited by 1,989 · cited 1×
“We selected CVD as the primary outcome of interest because it is a leading burden of disease, morbidity, and mortality (15).”
MethodJonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
Self-citationThe Rotterdam Study: objectives and design update
Hofman, A., Breteler, M. M. B., van Duijn, C. M., Krestin, G. P., Pols, H. A., Stricker, B. H. C., Tiemeier, H., Uitterlinden, A. G., Vingerling, J. R., & Witteman, J. C. M. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9199-x · Cited by 1,395
Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality
Rodondi, N., den Elzen, W. P. J., Bauer, D. C., Cappola, A. R., Razvi, S., Walsh, J. P., Åsvold, B. O., Iervasi, G., Imaizumi, M., Collet, T.-H., et al. (2010) · JAMA · doi:10.1001/jama.2010.1361 · Cited by 1,216
Self-citation2013 ETA Guideline: Management of Subclinical Hypothyroidism
Pearce, S. H. S., Brabant, G., Duntas, L. H., Monzani, F., Peeters, R. P., Razvi, S., & Wemeau, J.-L. (2013) · European Thyroid Journal · doi:10.1159/000356507 · Cited by 877
Self-citationSurks, M. I., & Hollowell, J. G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1499 · Cited by 750
Andersen, S., Pedersen, K. M., Bruun, N. H., & Laurberg, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8165 · Cited by 686 · cited 1×
“The intraindividual set point was much tighter than the interindividual set point, meaning that within an individual, changes in time were much smaller than changes between individuals (33).”
Background
Research works printed but not linked: 2
- 4. Chaker L, Baumgartner C, den Elzen WP, Collet TH, Ikram MA, Blum MR, Dehghan A, Drechsler C, Luben RN, Portegies ML, Iervasi G, Medici M, Stott DJ, Dullaart RP, Ford I, Bremner A, Newman AB, Wanner C, Sgarbi JA, Dorr M, Longstreth WT, Jr., Psaty BM, Ferrucci L, Maciel RM, Westendorp RG, Jukema JW, Ceresini G, Imaizumi M, Hofman A, Bakker SJ, Franklyn JA, Khaw KT, Bauer DC, Walsh JP, Razvi S, Gussekloo J, Volzke H, Franco OH, Cappola AR, Rodondi N, Peeters RP, Thyroid Studies C. Thyroid Function Within the Reference Range and the Risk of Stroke: An Individual Participant Data Analysis. J Clin Endocrinol Metab 2016; 101:4270-4282
- 10. Blum MR, Bauer DC, Collet TH, Fink HA, Cappola AR, da Costa BR, Wirth CD, Peeters RP, Asvold BO, den Elzen WP, Luben RN, Imaizumi M, Bremner AP, Gogakos A, Eastell R, Kearney PM, Strotmeyer ES, Wallace ER, Hoff M, Ceresini G, Rivadeneira F, Uitterlinden AG, Stott DJ, Westendorp RG, Khaw KT, Langhammer A, Ferrucci L, Gussekloo J, Williams GR, Walsh JP, Juni P, Aujesky D, Rodondi N, Thyroid Studies C. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA 2015; 313:2055-2065
Cited by
Taylor, P. N., Medici, M. M., Hubalewska-Dydejczyk, A., & Boelaert, K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01614-3 · Cited by 128
Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers
Jonklaas, J., & Razvi, S. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30371-1 · Cited by 100
Razvi, S., Bhana, S., & Mrabeti, S. (2019) · Journal of Thyroid Research · doi:10.1155/2019/4106816 · Cited by 90
“An alternative approach could be to define optimal ranges for TSH and FT4 based on risk engine-derived estimates of the risk of adverse cardiovascular outcomes, in a manner analogous to that used for setting treatment goals in the management of serum lipids [43].”
ResultSubclinical hypothyroidism in older individuals
Biondi, B., & Cappola, A. R. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00285-0 · Cited by 98
Self-citationTaylor, P. N., Lansdown, A., Witczak, J., Khan, R., Rees, A., Dayan, C. M., & Okosieme, O. (2023) · Thyroid Research · doi:10.1186/s13044-023-00149-5 · Cited by 72
“These considerations have generated intense debate as to whether the existing approach to establishing thyroid reference ranges should be refined [12, 13].”
BackgroundHoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00364 · Cited by 69
Xu, Y., Derakhshan, A., Hysaj, O., Wildisen, L., Ittermann, T., Pingitore, A., Abolhassani, N., Medici, M., Kiemeney, L. A. L. M., Riksen, N. P., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00227-9 · Cited by 61
Self-citationThyroid Function Affects the Risk of Stroke via Atrial Fibrillation: A Mendelian Randomization Study
Marouli, E., Kus, A., Del Greco M, F., Chaker, L., Peeters, R., Teumer, A., Deloukas, P., & Medici, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa239 · Cited by 57
“While several other populationbased studies have not found associations between normal range thyroid function and the risk of CAD only, most of these studies did show associations with increased CAD mortality (8, 39-41).”
BackgroundSelf-citationThe Genetic Basis of Thyroid Function: Novel Findings and New Approaches
Kuś, A., Chaker, L., Teumer, A., Peeters, R. P., & Medici, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz225 · Cited by 44
“This has opened up a discussion whether reference ranges for thyroid function tests should be adapted (74, 75).”
BackgroundSelf-citationKim, J. H., Lee, H. S., Kim, Y. H., Kwon, M. J., Kim, J., Min, C., Yoo, D. M., & Choi, H. G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.815063 · Cited by 43
Oh, H., Kwon, H., Ahn, J. H., Song, E., Park, S., Kim, M., Han, M., Jeon, M. J., Kim, W. G., Kim, W. B., et al. (2018) · Thyroid · doi:10.1089/thy.2017.0656 · Cited by 27
Brenowitz, W. D., Han, F., Kukull, W. A., & Nelson, P. T. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.004 · Cited by 23
“…hippocampal sclerosis of aging/cerebral age-related TDP-43 with sclerosis (CARTS), autoimmune disease(s), and, possibly, Alzheimer’s disease (AD) (Chaker et al., 2017; Chaker et al., 2016b; Collet et al., 2012; de Jong et al., 2009; Frohlich and Wahl, 2017; Mafrica and Fodale, 2008; Nelson et…”
BackgroundBano, A., Chaker, L., Mattace-Raso, F. U. S., Terzikhan, N., Kavousi, M., Ikram, M. A., Peeters, R. P., & Franco, O. H. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002957 · Cited by 26
“However, over the past years, there has been an ongoing debate on whether the reference ranges of TSH and FT4 levels should be re-evaluated [11,12].”
BackgroundSelf-citationChallenges in the Management of Atrial Fibrillation With Subclinical Hyperthyroidism
Gencer, B., Cappola, A. R., Rodondi, N., & Collet, T. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.795492 · Cited by 28
“SCTD are associated with increased risk of stroke, both in subclinical hypothyroidism (50) and in subclinical hyperthyroidism (51).”
BackgroundSelf-citationde Miranda, É. J. F. P., Hoshi, R. A., Bittencourt, M. S., Goulart, A. C., Santos, I. S., Brunoni, A. R., Diniz, M. F. H. S., Ribeiro, A. L. P., Dantas, E. M., Mill, J. G., et al. (2018) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20187704 · Cited by 23
“(35) also suggested a U-shaped relation between thyroid function and the risk of sudden cardiac death.”
BackgroundZhang, K., Meng, X., Wang, W., Zheng, J., An, S., Wang, S., Qi, Y., Gao, C., & Tang, Y. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02386 · Cited by 16
“Low thyroid function is very frequent in heart failure and is increasingly shown to be a strong and independent predictive marker of poor prognosis in cardiac patients (5, 6, 28, 29).”
BackgroundRazvi, S., Jabbar, A., Addison, C., Vernazza, J., Syed, A. A., Soran, H., & Leng, O. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad016 · Cited by 11
Li, X., Yao, Y., Chen, Z., Fan, S., Hua, W., Zhang, S., & Fan, X. (2018) · Clinical Cardiology · doi:10.1002/clc.23117 · Cited by 10
Hoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2020) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2020.100219 · Cited by 12
Camacho-Mejorado, R., Gómez, R., Torres‐Sánchez, L., Hernández-Tobías, E. A., Noris, G., Santana, C., Magaña, J. J., Orozco, L., de la Peña-Díaz, A., Arenas‐Sordo, M. D. L. L., et al. (2020) · Royal Society Open Science · doi:10.1098/rsos.190775 · Cited by 8
“Hence, the thyroid function should be defined through THs levels in the general population, as in health and disease conditions, and by age, sex and ethnicity [86].”
BackgroundTreatment of subclinical hypothyroidism: assessing when treatment is likely to be beneficial
Leng, O., & Razvi, S. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1738924 · Cited by 9
“Analysis of outcomes from participants from the Rotterdam study suggested that defining optimal reference ranges based on subsequent absolute 10-year cardiovascular disease mortality risk may be a more clinically useful marker than statistically derived ones [152].”
BackgroundThyroid disease in the elderly
Limanova, Z. (2018) · Vnitřní lékařství · doi:10.36290/vnl.2018.144 · Cited by 6
Liu, C., Zhong, X., & Hua, L. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110811 · Cited by 5
Co-PATHOgenex web application for assessing complex stress responses in pathogenic bacteria
Fernández, L., Rosvall, M., Normark, J., Fällman, M., & Avican, K. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02781-23 · Cited by 5
“Streptolysin S, a peptide toxin generated by GAS, can induce lysis of red blood cells in humans, thereby conferring an advantage to the pathogen through the utilization of hemoglobin as a source of iron (19).”
BackgroundDietrich, J. W., Makimoto, H., & Müller, P. (2019) · Circulation Heart Failure · doi:10.1161/circheartfailure.118.005854 · Cited by 4
Treatment options for subclinical hypothyroidism
Hoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1405 · Cited by 3
Fitzgerald, S. P., Falhammar, H., & Hoermann, R. (2023) · Thyroid · doi:10.1089/thy.2023.0496 · Cited by 4
Dischinger, U., & Faßnacht, M. (2018) · Der Internist · doi:10.1007/s00108-018-0441-2 · Cited by 3
Libertini, G., Corbi, G., Conti, V., Shubernetskaya, O. S., & Ferrara, N. (2021) · Advances in studies of aging and health · doi:10.1007/978-3-030-73774-0_3 · Cited by 2
Basic Concepts and a Brief History of Evolutionary Medicine
Libertini, G., Corbi, G., Shubernetskaya, O. S., Komici, K., & Ferrara, N. (2024) · Advances in studies of aging and health · doi:10.1007/978-3-031-84877-3_1 · Cited by 1
Alekseeva, O. A., Иосифович, Ш. И., & Богданов, Д. В. (2019) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2019-47-013 · Cited by 1
Marouli, E., Kuś, A., Fabiola Del Greco, M., Chaker, L., Peeters, R. P., Teumer, A., Deloukas, P., & Medici, M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/718429
Self-citationDischinger, U., & Faßnacht, M. (2018) · Der Internist
Metadata
- Authors
- Chaker, L., Korevaar, T. I. M., Rizopoulos, D., Collet, T.-H., Völzke, H., Hofman, A., Rodondi, N., Cappola, A. R., Peeters, R. P., & Franco, O. H.
- Affiliations
- Erasmus MC (NL)
- Centre Hospitalier Universitaire Vaudois (CH)
- Universitätsmedizin Greifswald (DE)
- University of Bern (CH)
- University of Pennsylvania (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2017-05-17
- Volume
- 102
- Issue
- 8
- Pages
- 2853-2861
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2616814370
- Cited by
- 33
- References
- 31
- Citations by year
- 2024: 2 · 2023: 6 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 6 · 2018: 7 · 2017: 2
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- SERVAL (Université de Lausanne) (acceptedVersion, other-oa)
- IRIS (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- BORIS (University Library Bern) (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Open Access CRIS of the University of Bern
- Funders
- National Science Foundation
- Veracyte
- European Commission (HORIZON2020, 634453)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (167826)
- ZonMw (91212044)
- Erasmus Universiteit Rotterdam
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Nestec
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- thyroid function, thyroid-stimulating hormone, free thyroxine, cardiovascular mortality, reference values, competing risk model, sex differences, age differences, older adults, thyroid dysfunction
- MeSH terms
- Aged, Cardiovascular Diseases, Female, Follow-Up Studies, Humans, Male, Middle Aged, Reference Values, Risk, Thyroid Diseases, Thyroid Function Tests, Thyrotropin, Thyroxine, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.